ArisGlobal, a leading AI-focused technology company in the Life Sciences sector, has announced five major new product launches. These innovations aim to enhance how different teams within pharmaceutical companies work together using artificial intelligence. The announcements came during the first day of their annual event, Breakthrough 2026, showcasing their latest advancements to the industry.

Introducing XDI: The Next-Generation Data Intelligence Cortex

The standout product is XDI, ArisGlobal’s new data intelligence platform designed to unify data from various functions across a pharma company’s operations. Unlike traditional tools that focus on speeding up individual tasks, XDI provides a system-agnostic foundation. It connects data from different systems and makes decisions that are transparent and explainable.

This platform helps ensure that decisions made in areas like safety, regulatory compliance, clinical trials, quality, and manufacturing are based on shared meaning and consistent evidence. It aligns different teams by providing clear context and governance, reducing misunderstandings and risks associated with interpretive differences. Overall, XDI is designed to promote confident AI adoption across the entire enterprise.

New AI Agents Boost Regulatory and Data Processes

ArisGlobal also expanded its NavaX Agents Suite with three new AI-powered agents that improve regulatory intelligence, change distribution, and signal detection. The Regulatory Intelligence Agent automatically interprets complex regulatory guidelines, converting them into checklists that help assess whether submissions meet compliance standards. It provides detailed evaluations, justifications, and confidence scores, making the review process more consistent and efficient.

The Change Distribution Agent keeps pace with evolving regulations by continuously validating new guidelines against internal workflows. When discrepancies are found, it automatically triggers change management processes, ensuring ongoing compliance. The Signals Agent acts as an intelligent assistant that interprets user needs, determines the best analytical approach, and orchestrates workflows across safety, data, and analytics. This active partner helps teams make faster, more informed decisions by intelligently managing complex data and processes.

NavaX Translation: Accelerating Global Data Intake

Another key announcement is NavaX Translation, a new feature integrated directly into case data workflows through a partnership with TransPerfect Life Sciences. This solution uses certified translation technology to instantly route non-English safety forms for translation using pharma-specific language models and expert linguists. The translated forms are then returned into the company’s system seamlessly via API, greatly reducing manual effort.

By combining NavaX with TransPerfect, ArisGlobal significantly cuts translation time from around five hours per case to under a minute. This automation speeds up global pharmacovigilance activities and reduces errors, making it easier for companies to manage international safety data efficiently. The overall goal is to streamline global operations and improve data accuracy across borders.

These product launches reflect ArisGlobal’s focus on integrating AI deeply into life sciences workflows. The company believes that smarter data management and automation will help the industry operate more confidently, efficiently, and in compliance with evolving regulations. As these tools roll out, they are expected to set new standards for how pharma companies leverage AI to advance their work and bring medicines to market faster.

Inspired by

• https://ai-techpark.com/arisglobal-announced-five-significant-new-product-offerings/